According to Greg Thurber, PhD, target-mediated uptake is the biggest driver of efficacy for antibody-drug conjugates as a cancer treatment.
Greg Thurber, PhD
Advertisement
Articles by Greg Thurber, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab
2
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer
3
Mecbotamab Vedotin Shows Positive OS Results in Soft Tissue Sarcoma
4
Novel Anti-CD5 Therapy Earns FDA RMAT Designation in T-Cell Lymphoma
5
